To assess DNA repair activity relative to age, in vitro base excision repair assays were performed using brain and liver nuclear extracts prepared from mice of various ages. An 85% decline in repair activity was observed in brain nuclear extracts and a 50% decrease in liver nuclear extracts prepared from old mice compared with 6-day-old mice. Brain nuclear extracts prepared from old mice showed a decreased abundance of DNA polymerase-b, but the addition of purified protein did not restore base excision repair activity. Abundances of other tested base excision repair proteins did not change relative to age. The conclusion is that, during aging, a decline in DNA repair could contribute to increased levels of DNA damage and mutagenesis.
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W HILE it is clear that organisms age and develop agerelated pathologies such as cancer, conclusive identification of the mechanisms involved in aging remain elusive. More than 40 years ago, Failla (1) and Szilard (2) proposed the Somatic Mutation Theory of Aging. The theory proposes that a gradual accumulation of mutations occurs with increasing age, thereby leading to cellular dysfunction and a breakdown of homeostasis. A role for genetic instability in carcinogenesis, largely an age-related pathology, is now well accepted (3), but whether genetic instability contributes substantially to overall organismal aging is not clear. Notably, correlative data support the Somatic Mutation Theory of Aging (4) (5) (6) (7) (8) (9) (10) . Later, Alexander (11) developed the DNA Damage Theory of Aging to explain aging based on accumulation of DNA damage: a theory that has been supported by correlative data (12) (13) (14) (15) .
Because DNA repair is tightly linked with levels of DNA damage and mutagenesis, many studies have focused on the potential role of DNA repair in aging. Indirect assessment of DNA repair has dominated studies designed to examine the potential role of decreased DNA repair in aging. These studies have included measurements of chromosomal aberrations (4, 16) , unscheduled DNA synthesis (17) , abundances of DNA lesions (12) (13) (14) 18, 19) , the activity of specific DNA repair proteins (13, 20, 21) , and the ability to remove induced damage (19, 22) . In general these studies have revealed decreased DNA repair activity with increased age. Because accumulation of spontaneous DNA damage and mutations has been hypothesized to contribute to aging, and because the base excision repair (BER) pathway is the pathway that largely ameliorates such damage (23) , BER may play an important role in aging. In general, BER involves the action of specific DNA glycosylases that catalyze hydrolysis of the N-glycosylic bond of damaged bases leaving apurinic/apyrimidinic (AP) sites in DNA. Some DNA glycosylases are bifunctional and nick the phosphodiester backbone 39 of the abasic site (24) . Most abasic sites are next processed by AP endonuclease (Ape), which nicks the phosphodiester backbone 59 of the abasic site (25, 26) . A DNA polymerase fills in the resulting gap (27, 28) . The 39-terminus of the original nick is processed to leave a 59 phosphate group as a suitable terminus for DNA ligase to complete repair of the damaged DNA strand by joining of the 59 phosphate to the 39 hydroxyl group of the newly replaced bases (27) .
Short-patch and long-patch BER pathways have been described. During short-patch BER, DNA polymerase b (bpol) incorporates a single nucleotide into the strand undergoing repair (28) , and DNA ligase III, with its partner Xrcc1, restores the integrity of the phosphodiester backbone (29) . Long-patch BER utilizes PCNA and DNA polymerase d or e to incorporate 2-6 nucleotides in the strand undergoing repair (30) . Fen-1 may be involved in removing the displaced flap (31) , and DNA ligase I rejoins the phosphodiester backbone (32) . It has been suggested that short-patch BER is more active than long-patch BER in vivo (25) .
To test if BER activity changes with age, an in vitro uracil DNA glycosylase (UDG)-initiated BER assay was used to examine short-patch BER. Repair activity was examined in nuclear extracts prepared from brain and liver of neonatal 
METHODS

Animals
Six-and 8-d/o neonatal and 3-m/o young adult male CD1 mice and neonatal B 6 D 2 F 1 mice were obtained from Charles River. Young adult (3-m/o), middle-aged (16-m/o), and old (28-m/o) male B 6 D 2 F 1 mice were obtained from the National Institute on Aging. All mice were housed in a specific-pathogen-free, American Association for the Accreditation of Laboratory Animal Care-accredited animal facility and fed standard mouse lab chow and water ad libitum. Adult mice were euthanized using isofluorane followed by cervical dislocation, while neonatal mice were overdosed with isofluorane. Tissues were rapidly removed and used immediately for preparation of nuclear extracts.
Nuclear Extracts
Brain and liver nuclear extracts were prepared as described by Widen and Wilson (33) , with modification as described previously (34, 35) . Luciferase (2.5 ng/ll) was added to the nuclear preparations just prior to lysis and subsequently used to assess protein recovery. Immunoglobulin was used as a standard in the Bradford assay (36) to determine overall protein concentrations according to the manufacturer's recommendations (BioRad, Hercules, CA). Nuclear extracts were separated into single-use aliquots at 10 mg/ml and stored at 2808C until use. Luciferase assays were performed on nuclear extracts prior to use in repair assays or Western analyses, as described previously (34, 35) , by adding 2 ll of nuclear extract to luciferase buffer (60 mM Tris-acetate [pH 7.5], 2.5 mM EDTA, 12 mM Mg acetate, 60 mM dithiothreitol, 5 mM ATP, 0.075% BSA, and 150 lM luciferin), measuring relative light units (RLUs) on a Lumat LB 9501 luminometer (Berthold), and comparing the RLUs to a luciferase standard curve (37, 38) .
UDG-BER Assay
The UDG-BER assay was performed as described previously (28, 34, 35) . Routinely, 40 lg of somatic tissue nuclear extract was added to a reaction mix consisting of 3 pmol of a 51-mer oligonucleotide containing a single G:U mismatch and a 59 fluorescein label on the U-containing strand (Integrated DNA Technologies) and reaction buffer (100 mM Tris-HCl, pH 7.5, 0.1 mM EDTA, 5 mM MgCl 2 , 1 mM dithiothreitol, 2 mM ATP, 0.5 mM NAD, dATP, dGTP, and dTTP at 20 lM each, 5 mM ditrisphosphocreatine, 10 units of creatine phosphokinase, 20 nM of unlabeled dCTP, 20 lCi of [a-
33 P]dCTP (3000 Ci/mmol)). Samples were incubated for 10 minutes at 378C. Reactions were stopped by the addition of stop solution (50 mM EDTA, 0.3 M NaCl, and 80% formamide) and placed on ice. Samples were then subjected to denaturing polyacrylamide (12%) gel electrophoresis. Fluorescently labeled oligonucleotide standards encompassing the linear range of fluorescent quantification were simultaneously run on each gel. The recovered oligonucleotide was visualized and quantified on a ChemiImage 4400 (Alpha Innotech, San Leandro, CA) while radionucleotide incorporation was measured using a GS-363 Molecular Imager System (BioRad). 
Western Blot Analysis
Western blot analyses were performed as described (34, 35) . Briefly, nuclear extracts prepared from brain and liver obtained from neonatal, young, middle-aged, and old mice were separated using SDS-PAGE on a 10% gel (acrylamide: bis-acrylamide 29:1), followed by electroblotting onto Trans-Blot Transfer Medium (BioRad). Blots were cut into three sections based on molecular mass to facilitate detection of specific antigens. DNA ligases I and III were detected by rabbit polyclonal antiligase I and ligase III antibodies (A. Tomkinson, University of Texas Health Science Center at San Antonio, San Antonio, TX), respectively. Xrcc1 was detected with rabbit anti-hXRCC1 polyclonal antibody (Serotec, Raleigh, NC). 
Statistical Analysis
UDG-BER and western blot data were analyzed using analysis of variance. Comparisons among means were Bonferroni adjusted. Changes in UDG-BER activity of nuclear extracts after the addition of purified BER proteins were compared using Dunnett's test. P values are presented from analysis of log-transformed data, whereas means and standard errors computed from untransformed data are presented. P values ,.05 were considered significant.
RESULTS
In Vitro BER Activity in Brain and Liver Nuclear Extracts UDG-BER activity was greater in liver nuclear extracts than brain nuclear extracts from mice in each of the ages that were tested: neonatal, young, middle-aged, and old ( p , .05; Figure 1A and B). UDG-BER activity was slightly but significantly lower in liver nuclear extracts prepared from 3-m/o mice compared with 6-d/o mice ( p , .05). Further reduction in UDG-BER activity was observed in liver nuclear extracts prepared from 16-and 28-m/o mice, such that a 50% decrease in UDG-BER activity was detected between liver nuclear extracts prepared from neonatal and old mice ( Figure 1A) . Figure 1B ). UDG-BER activity in brain nuclear extracts obtained from 28-m/o mice was 14% of that observed for neonatal mice. Overall, brain nuclear extract UDG-BER activity was observed to decline approximately 85% between neonatal and old mice.
BER Protein Abundances in Nuclear Extracts
Western blot analysis was used to determine the proportional abundances of BER proteins in nuclear extracts prepared from liver and brain isolated from young, middle aged, and old mice (Figure 2) . The proportional abundances of DNA ligases I and III, Xrcc-1, b-pol, and Ape in nuclear extracts from liver did not change significantly with increased age (Table 1) . Likewise, no significant changes in the proportional abundances of DNA ligase I and III, Xrcc-1, and Ape in brain nuclear extracts prepared from different age mice were detected ( Table 2 ). The abundance of b-pol in brain nuclear extracts from 28-m/o mice was reduced by 70% ( p , .05) and 40% (not statistically significant) compared with samples prepared from 3-and 16-m/o mice, respectively.
Limiting BER Enzyme Activities in Brain and Liver Nuclear Extracts
To determine if the abundance of a particular protein limited the UDG-BER activity in brain and liver nuclear extracts prepared from young and old mice, individual BER proteins were added to the extracts, which were subsequently assayed for activity. Addition of udg, APE/REF-1, b-POL, and DNA ligase III did not significantly alter UDG-BER activity in liver nuclear extracts prepared from 3-or 28-m/o mice ( Figure 3) . Likewise, UDG-BER activity was not affected by the addition of up to 20 ng purified udg, 
DISCUSSION
The potential role of DNA damage and mutagenesis in aging has been controversial in part because, while there are many studies showing an association between increased age and increased genomic instability (4) (5) (6) (7) (8) (9) (10) (12) (13) (14) , there are also studies that have not detected increased genomic instability with increased age (39, 40) . The decreased in vitro UDG-BER activity observed in brain and liver nuclear extracts prepared from old animals in our study is consistent with increased genomic instability with increased age and with a recent study demonstrating reduced short-patch BER in old mice compared with young adult mice (41) .
UDG-BER activity varies among mouse tissues with spermatogenic cell types exhibiting the highest level among tested cell and tissues types followed by mitotically active Sertoli cells, mitotically active thymocytes, small intestine, liver, and brain, but does not differ for a specific cell or tissue type between young adult C57BL/6J, CD1, and B 6 D 2 F 1 mice (34). The present study demonstrates that UDG-BER activity is higher in neonatal brain and liver than in corresponding adult tissues. Only one difference has been found between tested strains. BER activity in brain nuclear extracts prepared from 8-d/o CD1 mice was lower than samples obtained from 8-d/o B 6 D 2 F 1 mice, but the overall trend was similar, such that activity was highest in 6-d/o mice and declined through 28-m/o.
A 50% reduction in UDG-BER activity has been observed in spermatogenic cells obtained from old mice compared with young mice and coincided with a 50% reduction in the relative abundance of Ape (35) . Addition of purified APE/REF-1 to extracts prepared from old mice restored UDG-BER activity (35) . In contrast, addition of purified udg or DNA ligase III elevated UDG-BER activity in nuclear extracts prepared from young mice. These results suggested that different enzyme activities limited UDG-BER activity in samples prepared from young versus old mice.
Unlike spermatogenic cell types, addition of single BER proteins did not alter UDG-BER activity in brain or liver nuclear extracts prepared from young or old mice. Thus, these results for somatic tissues are very different from results using spermatogenic cells and lead to the suggestion that coordination and/or regulation of BER is different between somatic and germline cells. The 80% reduction in UDG-BER activity observed in brain nuclear extracts in the current study coincided with reduced abundance of b-pol and is consistent with data of Cabelof et al. (41) . Rao et al. (21) described reduced polymerase activity in neurons obtained from old rats, which could be restored by the addition of recombinant b-pol. The activities assessed by Rao et al. (21) consisted of 39-59 exonuclease activity and polymerase extension. BER activity was not examined directly. In the present study, addition of purified b-POL did not restore UDG-BER activity. Our results suggest that although b-pol levels decrease with age, the reduced abundance by itself is not a major factor limiting UDG-BER activity. Cabelof et al. (41) also detected reduced b-pol in liver samples prepared from old mice while our study did not detect a change. The difference may be due to the different strains of mice used. Cabelof et al. used the inbred C57BL strain, while we used a hybrid strain, B 6 D 2 F 1 .
The relatively constant abundances of other BER proteins through the range of ages that were tested, combined with the unaltered activity with the addition of specific purified BER proteins, suggests that the abundance of any of the individual BER proteins tested is not the mechanism by which UDG-BER activity is limited in somatic tissues of young mice, nor the mechanism by which activity is decreased relative to age in brain and liver. What then limits UDG-BER activity in brain and liver nuclear extracts? There are several possible explanations. (a) Perhaps Xrcc1, not added to nuclear extracts in this study, is a limiting protein. Xrcc1 RNA (42, 43) and protein abundances (Table 1) could also explain why the addition of single BER proteins does not restore UDG-BER activity in nuclear extracts of somatic tissues obtained from old animals because more than one protein would be involved in mediating the decline. Supporting this hypothesis are results showing that oxidatively damaged proteins accumulate with age (44) and inactive b-pol accumulation has been observed with increased age in neuronal extracts prepared from rats (20) . (d) Increased abundances of BER inhibitors might be found in extracts prepared from old mice. (e) Finally, various combinations of the above are possible.
In summary, this study has demonstrated that UDG-BER activity declines in nuclear extracts prepared from brain and liver in an age-related manner. The assay used interrogates the ability of extracts to repair uracil in DNA via the shortpatch BER pathway. To better understand the possible contribution of BER to increased genomic instability with increased age, repair of additional lesions must be examined, and for somatic tissues, short-and long-patch BER must be assessed. 
